These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 23808266
1. [Molecular and pharmacogenetic mechanisms of severe asthma]. Kulikov ES, Ogorodova LM, Freĭdin MB, Deev IA, Selivanova PA, Fedosenko SV, Kirillova NA. Vestn Ross Akad Med Nauk; 2013; (3):15-23. PubMed ID: 23808266 [Abstract] [Full Text] [Related]
2. [PHARMACOGENETIC MARKERS OF THE EFFECTIVENESS OF TREATMENT OF CHILDREN WITH ATOPIC BRONCHIAL ASTHMA.]. Balabolkin II, Bulgakova VA. Eksp Klin Farmakol; 2016; 79(11):35-40. PubMed ID: 29791107 [Abstract] [Full Text] [Related]
3. How pharmacogenomics will play a role in the management of asthma. Wechsler ME, Israel E. Am J Respir Crit Care Med; 2005 Jul 01; 172(1):12-8. PubMed ID: 15778484 [No Abstract] [Full Text] [Related]
4. Genetics and the variability of treatment response in asthma. Israel E. J Allergy Clin Immunol; 2005 Apr 01; 115(4 Suppl):S532-8. PubMed ID: 15806036 [Abstract] [Full Text] [Related]
5. β2-Adrenergic receptor Gly16Arg polymorphism and impaired asthma control in corticosteroid-treated asthmatic adults. Manoharan A, Griffin B, Lipworth J, Berg J, Andrew N, Jackson C, Lipworth B. Ann Allergy Asthma Immunol; 2015 May 01; 114(5):421-3. PubMed ID: 25747787 [No Abstract] [Full Text] [Related]
6. Dissecting Asthma Transcriptomics: Does Site Matter? de Jong E, Bosco A. Am J Respir Cell Mol Biol; 2018 Feb 01; 58(2):144-146. PubMed ID: 29388830 [No Abstract] [Full Text] [Related]
14. The latest on the role of LAMAs in asthma. Cazzola M, Rogliani P, Matera MG. J Allergy Clin Immunol; 2020 Dec 01; 146(6):1288-1291. PubMed ID: 32603663 [No Abstract] [Full Text] [Related]
15. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. Slob EMA, Vijverberg SJH, Palmer CNA, Zazuli Z, Farzan N, Oliveri NMB, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH. Pediatr Allergy Immunol; 2018 Nov 01; 29(7):705-714. PubMed ID: 29992699 [Abstract] [Full Text] [Related]
16. Black clouds and black boxes: comment on "Long-acting β2-agonist step-off in patients with controlled asthma". Chan CM, Shorr AF. Arch Intern Med; 2012 Oct 08; 172(18):1375-6. PubMed ID: 22928180 [No Abstract] [Full Text] [Related]
17. Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort. Koster ES, Raaijmakers JA, Koppelman GH, Postma DS, van der Ent CK, Koenderman L, Bracke M, Maitland-van der Zee AH. Pharmacogenomics; 2009 Aug 08; 10(8):1351-61. PubMed ID: 19663678 [Abstract] [Full Text] [Related]
18. Genetic basis for personalized medicine in asthma. Portelli M, Sayers I. Expert Rev Respir Med; 2012 Apr 08; 6(2):223-36. PubMed ID: 22455494 [Abstract] [Full Text] [Related]
19. A new phenotype of asthma: chest tightness as the sole presenting manifestation. Shen H, Hua W, Wang P, Li W. Ann Allergy Asthma Immunol; 2013 Sep 08; 111(3):226-7. PubMed ID: 23987204 [No Abstract] [Full Text] [Related]
20. Pharmacogenetic approaches in the treatment of asthma. Sayers I, Hall IP. Curr Allergy Asthma Rep; 2005 Mar 08; 5(2):101-8. PubMed ID: 15683609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]